Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HARMONY 1
NL-OMON33230Phase 3Active, not recruiting
- Sponsor
- Bioprojet
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pitolisant in narcolepsy (3 arms), sponsored by Bioprojet. Primary endpoint: Epworth Sleepiness Scale. Started Oct 2009; status: active, not recruiting.
02
Drugs
pitolisant
03
Conditions
narcolepsy
Beyond the preview
Go deeper on NL-OMON33230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33230.